- Dec 11, 2019

Immunotherapy drug improves outcomes for some children with relapsed leukemia

New findings from a clinical trial show that treatment with the immunotherapy drug blinatumomab is superior to standard chemotherapy for children and young adults with high- or intermediate-risk B-cell acute lymphoblastic leukemia (B-ALL) that has relapsed.

Stopping a rare childhood cancer in its tracks

Pediatric Cancer Vaccine May Be ‘Too Good to Be True,’ But More Work Is Needed

New research identifies a potential treatment target for hepatoblastoma in children

Loneliness May Lead to Chronic Conditions Emotional Distress in Young Adult Cancer Survivors

Canadian Pediatric Cancer Consortium launches to advance research in paediatric cancer care

Oncological emergencies: A must know condition for families with childhood cancer

Colin Seaman is the boy with the Harry Potter cells

New drug combination may effectively treat often fatal childhood brain tumor

New Drug Shows ‘Encouraging’ Outcomes for Pediatric Brain Tumor Treatment

Genetic variant linked with increased risk of anthracycline-related cardiomyopathy

Recent Posts

Immunotherapy drug improves outcomes for some children with relapsed leukemia

Archive

Search By Tags